Convulsion and Conjunctivitis

Summary:

Conjunctivitis is found among people with Convulsion, especially for people who are male, 2-9 old.

The study analyzes which people have Conjunctivitis with Convulsion. It is created by eHealthMe based on reports of 56 people who have Convulsion from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Convulsion?

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body) is found to be associated with 1,855 drugs and 2,856 conditions by eHealthMe. Check the latest studies of Convulsion.

What is Conjunctivitis?

Conjunctivitis (pink eye) is found to be associated with 1,298 drugs and 1,640 conditions by eHealthMe. Check the latest studies of Conjunctivitis.



On Jul, 20, 2026

56 people who have Convulsion and Conjunctivitis are studied.

Would you have Conjunctivitis when you have Convulsion?

Gender of people who have Convulsion and experienced Conjunctivitis *:

  • female: 38.18 %
  • male: 61.82 %

Age of people who have Convulsion and experienced Conjunctivitis *:

  • 0-1: 0.0 %
  • 2-9: 37.78 %
  • 10-19: 8.89 %
  • 20-29: 15.56 %
  • 30-39: 2.22 %
  • 40-49: 11.11 %
  • 50-59: 13.33 %
  • 60+: 11.11 %

Common co-existing conditions for these people *:

  1. Asthma: 4 people, 7.14%
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 3.57%
  3. Renal Cell Carcinoma (a kidney cancer): 1 person, 1.79%
  4. Paronychia (infection in the tissues adjacent to a nail on a finger or toe): 1 person, 1.79%
  5. Back Pain: 1 person, 1.79%
  6. Breast Cancer: 1 person, 1.79%
  7. Enterococcal Infection: 1 person, 1.79%
  8. Fever: 1 person, 1.79%
  9. High Blood Pressure: 1 person, 1.79%
  10. Irritable Bowel Syndrome: 1 person, 1.79%

Common drugs taken by these people *:

  1. Lamictal: 9 people, 16.07%
  2. Dilantin: 9 people, 16.07%
  3. Phenytoin: 8 people, 14.29%
  4. Tegretol: 8 people, 14.29%
  5. Lamotrigine: 5 people, 8.93%
  6. Albuterol: 4 people, 7.14%
  7. Keppra: 4 people, 7.14%
  8. Topamax: 3 people, 5.36%
  9. Folic Acid: 3 people, 5.36%
  10. Depakote: 2 people, 3.57%

Common symptoms for these people *:

  1. Erythema Multiforme (a type of hypersensitivity reaction): 32 people, 57.14%
  2. Rashes (redness): 19 people, 33.93%
  3. Fatigue (feeling of tiredness): 17 people, 30.36%
  4. Fever: 14 people, 25.00%
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 12 people, 21.43%
  6. Swelling Face: 11 people, 19.64%
  7. Nasopharyngitis (inflammation of the nasopharynx): 9 people, 16.07%
  8. Scar: 9 people, 16.07%
  9. Hypoaesthesia (reduced sense of touch or sensation): 8 people, 14.29%
  10. Stomatitis (inflammation of mucous membrane of mouth): 8 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Conjunctivitis?

- Check whether Conjunctivitis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Conjunctivitis:

All the conditions that are associated with Conjunctivitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Conjunctivitis and Convulsion, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: